Enmetazobactam

Enmetazobactam (AAI101) is an extended-spectrum β-lactamase inhibitor, against many resistant Gram-negative pathogens[1][2].

Product Specifications

CAS Number

[1001404-83-6]

Product Name Alternative

AAI101

UNSPSC

12352005

Hazard Statement

H315, H317, H318, H334, H335, H341, H361, H370, H413

Target

Bacterial; Beta-lactamase

Type

Reference compound

Related Pathways

Anti-infection

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/AAI101.html

Purity

98.69

Solubility

DMSO : ≥ 113.3 mg/mL|H2O : ≥ 100 mg/mL

Smiles

C[N+]1=NN(C[C@@](S([C@]2([H])C3)(=O)=O)(C)[C@H](C([O-])=O)N2C3=O)C=C1

Molecular Formula

C11H14N4O5S

Molecular Weight

314.32

Precautions

H315, H317, H318, H334, H335, H341, H361, H370, H413

References & Citations

[1]Crandon JL, et al. In Vitro Activity of Cefepime/AAI101 and Comparators against Cefepime Non-susceptible Enterobacteriaceae. Pathogens. 2015 Aug 18;4 (3) :620-5.|[2]Crandon JL, et al. In vivo activities of simulated human doses of cefepime and cefepime-AAI101 against multidrug-resistant Gram-negative Enterobacteriaceae. Antimicrob Agents Chemother. 2015 May;59 (5) :2688-94.